Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Author and Disclosure Information [Show]

Zeina Nahleh, MD
Professor of Medicine and Biomedical Sciences, Chief, Division of Hematology-Oncology, Department of Internal Medicine, Co-Director, Garbar Breast Care Center, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX

Question 1 of 5

A 55-year-old otherwise healthy postmenopausal woman is diagnosed with a stage IIB T2N1M0 (size 3 × 2.5 × 2 cm) invasive ductal cancer, moderately differentiated. Hormone-receptor testing reveals estrogen-receptor (ER) 95% and progesterone receptor (PR) 20%, and HER2 status is negative. The patient undergoes lumpectomy and axillary lymph node dissection. Three out of 11 axillary lymph nodes are positive for metastatic cancer. Radiation therapy is planned.

Which of the following is the optimal therapeutic option for this patient?

Anastrozole for 5 years

Chemotherapy AC-GT (doxorubicin and cyclophosphamide followed by gemcitabine plus paclitaxel)

Chemotherapy AC-T (doxorubicin and cyclophosphamide followed by paclitaxel) or TC (docetaxel and cyclophosphamide) followed by endocrine therapy

Tamoxifen for 2 to 3 years followed by anastrozole for 3 years
Hospital Physician: Hematology/Oncology. 2015 November;11(6)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology

QUIZ

Autoimmune Hemolytic Anemia
Take Quiz
Gastrointestinal Stromal Tumors
Take Quiz
Testicular Cancer
Take Quiz
Management of Advanced Melanoma
Take Quiz
Castration-Resistant Prostate Cancer
Take Quiz
Transfusion Reactions (part 2)
Take Quiz
Transfusion Reactions (part 1)
Take Quiz
Plasma Cell Disorders (part 3)
Take Quiz
Plasma Cell Disorders (part 2)
Take Quiz
Chronic Myeloid Leukemia
Take Quiz
Aplastic Anemia
Take Quiz
Transfusion Medicine
Take Quiz
Management of Metastatic Gastric Cancer
Take Quiz
Small Cell Lung Cancer
Take Quiz
Acute Myeloid Leukemia
Take Quiz
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Take Quiz
Management of Colorectal Cancer in Older Adults
Take Quiz
Aggressive B-Cell Non-Hodgkin Lymphoma
Take Quiz
HER2-Positive Breast Cancer
Take Quiz
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
Take Quiz
Von Willebrand Disease: Clinical Management
Take Quiz
Von Willebrand Disease: Assessment and Diagnostic Testing
Take Quiz
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Take Quiz
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Take Quiz
Polycythemia Vera and Essential Thrombocythemia: Current Management
Take Quiz
Treatment of Biliary Tract Cancers
Take Quiz
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Take Quiz
Hairy Cell Leukemia
Take Quiz
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Take Quiz
Immune Thrombocytopenia
Take Quiz
Cancer-Related Fatigue
Take Quiz
Disseminated Intravascular Coagulation
Take Quiz
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Take Quiz
Adjuvant Chemotherapy for Colon Cancer
Take Quiz
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Take Quiz
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Take Quiz
Thrombosis in Pregnancy
Take Quiz
Locally Advanced Pancreatic Cancer
Take Quiz
Early-Stage Hodgkin Lymphoma
Take Quiz
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Take Quiz
Hemophilia A and B
Take Quiz
Mantle Cell Lymphoma
Take Quiz
Soft Tissue Sarcoma
Take Quiz
Sickle Cell Disease
Take Quiz
Renal Cell Carcinoma
Take Quiz
Management of Locally Advanced Rectal Adenocarcinoma
Take Quiz
Chronic Myeloid Leukemia
Take Quiz
Plasma Cell Disorders
Take Quiz
Myelodysplastic Syndromes
Take Quiz
Acute and Chronic Graft-versus-Host Disease
Take Quiz